{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:17:39Z","timestamp":1762507059127},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1093\/europace\/euw315","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T18:52:51Z","timestamp":1489603971000},"page":"1944-1950","source":"Crossref","is-referenced-by-count":22,"title":["Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation"],"prefix":"10.1093","volume":"19","author":[{"given":"Gordon A","family":"Begg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashed","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Oesterlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee N","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawal","family":"Rhode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun V","family":"Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Plein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzahir H","family":"Tayebjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"key\n\t\t\t\t20171129043832_euw315-B1","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171129043832_euw315-B2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.amjcard.2012.12.005","article-title":"Left ventricular fibrosis in atrial fibrillation","volume":"111","year":"2013","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171129043832_euw315-B3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCEP.115.002881","article-title":"Fibrosis, myofibroblasts, and atrial fibrillation","volume":"8","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20171129043832_euw315-B4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejcts.2010.11.008","article-title":"Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation","volume":"40","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"key\n\t\t\t\t20171129043832_euw315-B5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCRESAHA.107.163956","article-title":"Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation","volume":"101","year":"2007","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20171129043832_euw315-B6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cmpb.2015.12.007","article-title":"Analysis and visualization of intracardiac electrograms in diagnosis and research: concept and application of KaPAVIE","volume":"127","year":"2016","journal-title":"Comput Methods Programs Biomed"},{"key":"key\n\t\t\t\t20171129043832_euw315-B7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on Atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","year":"2016","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171129043832_euw315-B8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1540-8167.2011.02059.x","article-title":"Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence","volume":"22","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20171129043832_euw315-B9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/europace\/eus162","article-title":"Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion","volume":"14","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171129043832_euw315-B10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2016.01.179","article-title":"Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: a pilot study","volume":"207","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20171129043832_euw315-B11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2217\/bmm.15.121","article-title":"Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis","volume":"10","year":"2016","journal-title":"Biomark Med"},{"key":"key\n\t\t\t\t20171129043832_euw315-B12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2014.02.009","article-title":"Galectin 3 and incident atrial fibrillation in the community","volume":"167","year":"2014","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171129043832_euw315-B13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2016.02.100","article-title":"Predictive value of circulating fibroblast growth factor-23 on atrial fibrillation: a meta-analysis","volume":"210","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20171129043832_euw315-B14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.ajkd.2014.10.025","article-title":"Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study","volume":"66","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171129043832_euw315-B15","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1253\/circj.CJ-15-0413","article-title":"Circulating fibroblast growth factor 23 has a U-Shaped association with atrial fibrillation prevalence","volume":"79","year":"2015","journal-title":"Circ J"},{"key":"key\n\t\t\t\t20171129043832_euw315-B16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.113.005499","article-title":"Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS)","volume":"130","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171129043832_euw315-B17","doi-asserted-by":"crossref","first-page":"e001082","DOI":"10.1161\/JAHA.114.001082","article-title":"Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the atherosclerosis risk in communities study","volume":"3","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20171129043832_euw315-B18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0008-6363(02)00338-3","article-title":"Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro","volume":"55","year":"2002","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20171129043832_euw315-B19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ahj.2014.01.010","article-title":"Circulating fibrosis biomarkers and risk of atrial fibrillation: the Cardiovascular Health Study (CHS)","volume":"167","year":"2014","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171129043832_euw315-B20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","article-title":"The fibrosis marker galectin-3 and outcome in the general population","volume":"272","year":"2012","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20171129043832_euw315-B21","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2009-1619","article-title":"Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171129043832_euw315-B22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jacc.2004.10.035","article-title":"Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure.","volume":"45","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171129043832_euw315-B23","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.hrthm.2012.08.039","article-title":"Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations","volume":"9","year":"2012","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20171129043832_euw315-B24","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/jce.12452","article-title":"Contact electroanatomic mapping derived voltage criteria for characterizing left atrial scar in patients undergoing ablation for atrial fibrillation","volume":"25","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20171129043832_euw315-B25","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/europace\/euv045","article-title":"Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease","volume":"17","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171129043832_euw315-B26","doi-asserted-by":"crossref","first-page":"e0123574","DOI":"10.1371\/journal.pone.0123574","article-title":"Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation","volume":"10","year":"2015","journal-title":"PLoS One"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/19\/12\/1944\/22080228\/euw315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T04:40:07Z","timestamp":1511930407000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/europace\/article\/19\/12\/1944\/3057415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,2,27]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euw315","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,2,27]]}}}